Comparing nodal versus bony metastatic spread using tumour phylogenies

Stefano Mangiola; Matthew KH Hong; Marek Cmero; Natalie Kurganovs; Andrew Ryan; Anthony J Costello; Niall M Corcoran; Geoff Macintyre; Christopher M Hovens

Journal article

Comparing nodal versus bony metastatic spread using tumour phylogenies

Stefano Mangiola, Matthew KH Hong, Marek Cmero, Natalie Kurganovs, Andrew Ryan, Anthony J Costello, Niall M Corcoran, Geoff Macintyre, Christopher M Hovens

SCIENTIFIC REPORTS | NATURE PUBLISHING GROUP | Published : 2016

DOI: 10.1038/srep33918

Download PDF

University of Melbourne Researchers

Christopher Hovens Author Surgery - Royal Melbourne Hospital

Stefano Mangiola Author Medical Biology (W.E.H.I.)

Anthony Costello Author Surgery - Royal Melbourne Hospital

Niall Corcoran Author Surgery - Royal Melbourne Hospital

Marek Cmero Author The Sir Peter MacCallum Department of Oncology

Related Projects (3)

Determining the origin of lethal metastases in multifocal primary prostate cancer

New biomarkers are required to accurately predict lethal prostate cancer from benign, indolent disaese that doesn't require expensive treatm..

TRACKING THE ORIGINS AND DRIVERS OF METASTASIS IN PROSTATE CANCER

Prostate cancer is now the most commonly diagnosed cancer but only 10% of men with it, will die from it. Our current ability to discriminate..

Investigation of the source of new testosterone production in prostate tumours that become resistant to existing hormonal (testosterone lowering and blocking) therapies

Prostate cancer is critically dependent upon continued testosterone stimulation, even when the disease becomes resistant to existing hormona..

Grants

Awarded by NHMRC

Awarded by CRUK core grant

Funding Acknowledgements

We thank M. Kerger and P. Xibberas for tumour sample collection and patient disease annotation. We thank all members of the CMH laboratory for helpful comments and editing of this manuscript. This work was supported, in part, by NHMRC grants 1047581 and 1104010 to CMH and 1024081 to NMC. The Ovarian Cancer Action [BriTROC project grant: G.M]; The University of Cambridge, Cancer Research UK, Hutchinson Whampoa Limited, CRUK core grant C14303/A17197 (CRUK CI institute core grant, GM).